Dr. O'Neil on Emerging Therapeutic Techniques in Bladder Cancer

Brock O'Neil, MD
Published: Thursday, Jul 19, 2018



Brock O’Neil, MD, assistant professor, Division of Urology, University of Utah School of Medicine, Huntsman Cancer Institute, discusses emerging therapeutic techniques in bladder cancer.

There is a lot of interest in exploring robotic cystectomy, says O’Neil. The field is likely to move in that direction, especially by way of intracorporeal urinary diversions. The procedure is getting more established through ongoing clinical trials. Results from the RAZOR trial were recently presented that are promising and encouraging, states O’Neil.

However, the trial failed to show any significant benefits over complications. They seem to show equivalence in terms of oncologic outcomes, explains O’Neil. The biggest benefits come in blood loss and potentially length of hospital stay.

Another shift in the field is the push for early recovery after surgery protocols. Most centers that do cystectomies have those protocols in place and have shown shorter hospital lengths of stay. O’Neil notes that they may also have some impact on complications.

Wearable sensors, though fairly new, is another technique that has garnered a lot of attention. The ideology behind the sensors is early identification of postsurgical complications for early intervention.


Brock O’Neil, MD, assistant professor, Division of Urology, University of Utah School of Medicine, Huntsman Cancer Institute, discusses emerging therapeutic techniques in bladder cancer.

There is a lot of interest in exploring robotic cystectomy, says O’Neil. The field is likely to move in that direction, especially by way of intracorporeal urinary diversions. The procedure is getting more established through ongoing clinical trials. Results from the RAZOR trial were recently presented that are promising and encouraging, states O’Neil.

However, the trial failed to show any significant benefits over complications. They seem to show equivalence in terms of oncologic outcomes, explains O’Neil. The biggest benefits come in blood loss and potentially length of hospital stay.

Another shift in the field is the push for early recovery after surgery protocols. Most centers that do cystectomies have those protocols in place and have shown shorter hospital lengths of stay. O’Neil notes that they may also have some impact on complications.

Wearable sensors, though fairly new, is another technique that has garnered a lot of attention. The ideology behind the sensors is early identification of postsurgical complications for early intervention.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions & New Answers to Optimize OutcomesAug 16, 20181.5
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x